PB301 Target Overview
Limitations of stem cell therapy
Possibility of stem cell therapy using exosomes
MoA & Indication of PB301
Target (MoA) |
- Various Th17 cell targeting treatments using MSC-exosomes - Target : Th17 cell - MoA :
|
|
Indication |
- Autoimmune disease
|
Th17 cell-mediated autoimmune disease
Patent
No.1067742, 2011.09.20.
Domestic patent registration
Human neural stem cell-derived immunomodulatory microvesicles and uses thereof.
Patent
No.10-2017-0048667, 2018.04.16.
Patent application
Treatment of autoimmune diseases involving MSC-exosomes.